Abstract：
PURPOSE:Case reports and small case series have reported a high rate of complications associated with chest tube placement for hepatic hydrothorax. We describe the in-hospital and 3-month outcomes of patients who have had this procedure. METHODS:A retrospective medical record review was performed of all patients admitted to a tertiary care center over a 10-year period with a chest tube placed for hepatic hydrothorax. Demographic data and outcomes were collected and analyzed. RESULTS:Seventeen patients were identified; 12 were taking diuretics and 8 were taking multiple diuretics at the time of admission. MELD score was 14 (range = 7-34). During hospitalization, 16 had at least 1 and 12 had more than 1 complications. The most common complications were acute kidney injury (n = 11), pneumothorax (n = 7), and empyema (n = 5). Two patients died during the index admission and four others within 3 months of that admission. Six of seven patients who received TIPS survived. CONCLUSIONS:Chest tube insertion for hepatic hydrothorax carries significant morbidity and mortality, with questionable benefit.
journal_name
Hepatol Intjournal_title
Hepatology internationalauthors
Orman ES,Lok ASdoi
10.1007/s12072-009-9136-zsubject
Has Abstractpub_date
2009-12-01 00:00:00pages
582-6issue
4eissn
1936-0533issn
1936-0541journal_volume
3pub_type
杂志文章abstract：:Hepatitis B virus (HBV) reactivation with hepatic decompensation leading to acute on chronic liver failure is not uncommon. It is associated with high mortality of up to 30-70%. Prognostic factors for mortality include high bilirubin level, more prolonged prothrombin time, low platelet count and presence of pre-existi...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-014-9569-x
更新日期：2015-07-01 00:00:00
abstract：:Non-alcoholic fatty liver disease (NAFLD) is currently one of the leading forms of chronic liver disease, and its rising frequency worldwide has reached epidemic proportions. NAFLD, particularly its progressive variant NASH (non-alcoholic steatohepatitis), can lead to advanced fibrosis, cirrhosis, and HCC. The pathoph...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-018-9854-1
更新日期：2018-03-01 00:00:00
abstract：PURPOSE:To assess the accuracy of a formula derived from 159 living liver donors to estimate the liver size of a normal subject: standard liver weight (g) = 218 + body weight (kg) × 12.3 + 51 (if male). Standard liver volume (SLV) is attained by a conversion factor of 1.19 mL/g. METHODS:The total liver volume (TLV) of...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-011-9264-0
更新日期：2011-03-26 00:00:00
abstract：:Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease, characterized by multiple strictures and dilatations of the intra- and extrahepatic bile ducts, leading to progressive liver fibrosis, in 10-15% cholangiocarcinoma, and ultimately end-stage liver disease. The pathogenesis is poorly understood, b...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-020-10118-x
更新日期：2020-12-30 00:00:00
abstract：BACKGROUND AND AIMS:To estimate the impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma. METHODS:We searched Pubmed and Embase for original articles that evaluated the impact of hepatitis B virus infection on outcomes of intrahepatic cholangiocarcinoma. The present study was conducted to ...
journal_title：Hepatology international
pub_type： 杂志文章,meta分析,评审
doi：10.1007/s12072-018-9881-y
更新日期：2018-07-01 00:00:00
abstract：BACKGROUND:Compositional changes of the gut microbiota are known to occur in patients with nonalcoholic fatty liver disease (NAFLD); however, the changes did not corroborate between the studies. We evaluated the gut microbiota between NAFLD and non-NAFLD participants, excluding the influence of obesity and sex in this ...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-019-09987-8
更新日期：2019-11-01 00:00:00
abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is one of the most common malignant neoplasms worldwide. The p53 gene is frequently mutated in some histological subtypes of HCC. The role of p53 mutations and polymorphic variant of codon 72 in the prognosis of disease is still unclear. The p53 tumor suppressor gene Arg72Pro p...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-012-9389-9
更新日期：2013-06-01 00:00:00
abstract：:Spontaneous bacterial peritonitis (SBP) is a common cause of morbidity and mortality in patients with advanced cirrhosis and portal hypertension. While gram-negative rods and Enterococcus species are the common offending organisms, Salmonella has also been recognized as a rare and atypical offending organism. Atypical...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-008-9087-9
更新日期：2008-09-01 00:00:00
abstract：PURPOSE:All previous studies reported the benefit of antibiotic prophylaxis in cirrhotic patients with either a mixture of nonvariceal and variceal bleeding or variceal bleeding alone. Reports on sole peptic ulcers bleeding are lacking. We aimed to assess the effect of antibiotic prophylaxis in cirrhotic patients with ...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-012-9378-z
更新日期：2013-03-01 00:00:00
abstract：AIM:Tamibarotene is a synthetic retinoid expected to inhibit tumor-cell proliferation and to induce apoptosis by selective interaction with retinoic acid receptor α/β. We conducted an open-label phase I/II study to determine the maximum tolerated dose (MTD) and recommended dose (RD), and to evaluate the pharmacokinetic...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-013-9459-7
更新日期：2014-01-01 00:00:00
abstract：:Liver transplantation is a definitive therapy for patients with end-stage liver disease and cirrhosis, with improvement in survival and quality of life. Patients are carefully screened and selected for this modality of treatment to achieve maximum survival benefit. For example, a patient with hepatocellular carcinoma ...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-016-9770-1
更新日期：2017-01-01 00:00:00
abstract：:An ultrasound (US) examination is a common noninvasive technique widely applied for diagnosis of a variety of diseases. Based on the rapid development of US equipment, many US images have been accumulated and are now available and ready for the preparation of a database for the development of computer-aided US diagnos...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-019-09937-4
更新日期：2019-07-01 00:00:00
abstract：PURPOSE:To analyze the prognostic factors for the patients with lung metastases from hepatocellular carcinoma (HCC). METHODS AND MATERIALS:One hundred and five patients with lung metastases from HCC were analyzed retrospectively. We analyzed the impact factors, including the gender, age, liver function, serum AFP and ...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-008-9052-7
更新日期：2008-06-01 00:00:00
abstract：OBJECTIVE:Type II mixed cryoglobulinemia (MC) is a systemic vasculitis usually associated with hepatitis C virus (HCV). The present trial was performed to investigate the efficacy of therapy with pegylated interferon alfa-2a (PEG-IFN alfa-2a) plus ribavirin in patients with HCV-related MC vasculitis and evaluate the fa...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-011-9303-x
更新日期：2012-06-01 00:00:00
abstract：BACKGROUND AND AIMS:The peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand, piglitazone, enhances the degradation of branched-chain amino acids (BCAAs) in adipose tissue. However, it remains unknown whether pioglitazone influences the plasma amino acids (AA) profile in patients with nonalcoholic steatohepatit...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-012-9395-y
更新日期：2013-06-01 00:00:00
abstract：:Alcoholic liver disease (ALD) is a leading cause of liver-related morbidity and mortality worldwide. ALD encompasses a spectrum of disorders including asymptomatic steatosis, steatohepatitis, fibrosis, cirrhosis and its related complications, and the acute-on-chronic state of alcoholic hepatitis. While multidisciplina...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-015-9701-6
更新日期：2016-07-01 00:00:00
abstract：:Solitary necrotic nodules of the liver occur rarely. Although these nodules are usually benign, they are surgically removed in most cases because they cannot be differentiated from malignant lesions. To date, the natural history of solitary fibrous nodules remains unclear. We present the case of an incidentally detect...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-010-9199-x
更新日期：2010-07-29 00:00:00
abstract：PURPOSE:Clevudine 30 mg showed potent antiviral activity with a marked post-treatment antiviral effect. However, long-term treatment with clevudine monotherapy induced resistance and myopathy in some cases. The objective of this study is to evaluate the preliminary efficacy and safety of the combination of clevudine 20...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-014-9537-5
更新日期：2014-05-25 00:00:00
abstract：BACKGROUND:Early prediction of lamivudine (LAM) response by individualized monitoring of serum HBV DNA like roadmap concept, and investigation of the outcome after LAM discontinuation in renal transplant recipients (RTRs) with chronic hepatitis B (CHB). METHODS:We conducted a study on 19 RTRs with HBV infection receiv...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-011-9295-6
更新日期：2012-04-01 00:00:00
abstract：:The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wis...
journal_title：Hepatology international
pub_type： 社论,实务指引
doi：10.1007/s12072-018-09923-2
更新日期：2019-01-01 00:00:00
abstract：BACKGROUND AND AIM:Cirrhosis is a controversial determinant of mortality in HBV-related acute-on-chronic liver failure (HBV-ACLF). The present study aimed to explore the effects of cirrhosis and the associated risk factors, especially its complications, on the outcome of HBV-ACLF. METHODS:A prospective-retrospective c...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-019-09992-x
更新日期：2019-11-01 00:00:00
abstract：:Since their original identification, our understanding of the role of hepatic stellate cells in both health and disease continues to grow. Numerous studies have delineated the role of stellate cell activation in contributing to the pool of myofibroblasts responsible for liver fibrosis, and these have resulted in the d...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-016-9758-x
更新日期：2016-11-01 00:00:00
abstract：BACKGROUND AND AIMS:Ultrasonography is the most frequently used modality in surveillance for HCC among patients with chronic hepatitis C. However, the optimal surveillance interval is still controversial and the usefulness of supplementary tumor marker determination has not been confirmed. METHODS:A total of 243 cases...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-009-9145-y
更新日期：2009-12-01 00:00:00
abstract：BACKGROUND AND AIMS:Status 1A patients are prioritized over end-stage liver disease (ESLD) for liver transplantation (LT). ESLD patients with high MELD may have higher waitlist mortality than Status 1A patients, and may require LT more urgently. METHODS:Using United Network for Organ Sharing registry data, we retrospe...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-016-9735-4
更新日期：2016-09-01 00:00:00
abstract：BACKGROUND AND AIMS:Acute-on-chronic liver failure (ACLF) is associated with a high mortality rate in the absence of liver transplantation. There is limited data on predictors of survival in ACLF in children. Therefore, we prospectively studied the predictors of outcome of ACLF in children. METHODS:A prospective evalu...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-010-9217-z
更新日期：2011-06-01 00:00:00
abstract：:The presence of hepatic encephalopathy (HE) within 4 weeks is part of the criteria for defining acute-on-chronic liver failure (ACLF). The pathophysiology of HE is complex, and hyperammonemia and cerebral hemodynamic dysfunction appear to be central in the pathogenesis of encephalopathy. Recent data also suggest that ...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-015-9626-0
更新日期：2015-10-01 00:00:00
abstract：GOALS:The aim of our study is to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) and advanced hepatic fibrosis in patients with type 1 diabetes (T1D) using simple noninvasive scores. BACKGROUND:There is paucity of data on the prevalence of NAFLD in T1D. Moreover, T1D could be a risk factor for advanc...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-017-9840-z
更新日期：2018-01-01 00:00:00
abstract：:Hepatocellular carcinoma (HCC) is a common malignant tumor with high lethality, and the hepatitis B virus (HBV) is a chief cause. HBV can accelerate HCC via multiple mechanisms. First, HBV induces immune reactions that lead to repeated hepatic inflammation, fibrosis and a deficient immune microenvironment. Subsequentl...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-016-9779-5
更新日期：2017-03-01 00:00:00
abstract：PURPOSE:To evaluate the recent topics of Ballloon-occluded retrograde trasnvenous obliteration(B-RTO). METHOD:We overviewed the recent scientific papers regarding B-RTO. RESULT:B-RTO is a treatment method for occluding varices retrogradely using a sclerosing agent under balloon occlusion of a major draining vein. It ...
journal_title：Hepatology international
pub_type： 杂志文章,评审
doi：10.1007/s12072-017-9813-2
更新日期：2018-02-01 00:00:00
abstract：PURPOSE:Lamivudine treatment of chronic hepatitis B (CHB) is associated with frequent resistance and loss of clinical benefit. We present outcomes of lamivudine-refractory Japanese patients treated with entecavir for 3 years. METHODS:Eighty-two patients refractory to lamivudine therapy received entecavir 0.5 or 1 mg d...
journal_title：Hepatology international
pub_type： 杂志文章
doi：10.1007/s12072-009-9162-x
更新日期：2010-02-06 00:00:00
